Modern Football looks to revolutionize the game off the field
A startup has developed a football intelligence platform that provides coaches with the detailed tendencies of their opponents in real-time during games. The goal of Modern Football Technology’s proprietary platform is of course to help teams win games. “We’ve revolutionized how coaches approach their game strategy,” co-founder Christian Masegian, an alumni and former football player Read More →
Mercado: Ventura County’s growing biotech presence on full display
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Biotech Corridor event focuses on industry challenges
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Cognixion’s flagship product receives FDA breakthrough designation
Santa Barbara-based Cognixion has received a Breakthrough Device designation from the U.S. Food and Drug Administration, the company announced on May 4, paving the way to get its artificial intelligence-powered neural interface to the market faster. Cognixion was founded in 2014 by Andreas Forsland, under the name Smartstone at the time. With the designation, Cognixion Read More →
Biosimilar market continues cutting into Amgen’s top line
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CRELY leverages AI to change the healthcare industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s revenue dips in the first quarter, still beats earnings estimates
Thousand Oaks-based Amgen delivered a sound earnings beat in the first quarter of 2023, the company announced after the markets closed on April 27. Amgen, one of the largest biotechnology companies in the world, generated net income worth $2.8 billion in the first quarter or $5.28 earnings per share. This nearly doubled last year’s first-quarter Read More →
